- Low lab vacancy rates across life science markets reflect significant demand and limited supply of existing wet lab space.
- More than 36 million square feet of new construction is expected to be delivered in the top 14 life science markets across the United States.
- Institutional investors and landlords across the largest life science clusters are actively reevaluating “highest and best use” for their portfolios and are considering converting their properties to meet immediate life science demand.
- The concentration of life science investment volume as a percentage of total office volume reached a record high of 16.4% in 2020, more than double the 2019 figure.
- Average monthly pricing for United States life science investment sales has more than tripled from the May 2020 trough, reaching $627 PSF in December.
- Insights>
- Thought Leadership >
- 2020 Year-End: Life Science National Overview & To…
2020 Year-End: Life Science National Overview & Top Market Clusters
January 2021
The pandemic has accelerated both tenant and institutional investor demand for life science real estate in 2020, from wet lab and incubator space to biomanufacturing and R&D properties.
Related Insights
05.18.20
Real Insight
COVID-19 and the Future of the Life Sciences…
COVID-19 and the Future of the Life Sciences Sector
How will the pandemic affect tenant demand for specialized Life Sciences space, and what does the development environment look like?
View
08.02.19
Thought Leadership
NYC Life Sciences Overview
NYC Life Sciences Overview
With significant public and private funding, respected academic medical institutions and a large workforce, Life Sciences in New York City are set to emerge as a more…
View
02.02.21
Market Report
Boston Market Reports
Boston Market Reports
Following a banner year of activity, 2020 proved to be challenging for Greater Boston’s office market.
View